With the exception of osteosarcoma and pancreatic cancer [33,34,35], high CXCL10 expression is associated with favorable patient outcomes in various cancer types including breast, ovarian, liver, colon, rectum, esophagus, thyroid, and head and neck cancers [36,37,38,39,40,41,42,43]. This evidence concerns the gene CXCL10 and familial pancreatic carcinoma.